Sun Pharmaceutical Industries Limited CC-May26.pdf ·
Yes, hi. Thanks for taking my question. So just to understand this on the revenue side, so organic growth of Organon should we expect it to remain in the in the flattish range that we have seen in the past and to grow the business to say mid -to-high single digit, we would be depending essentially on the in -licensing deals? Is that understanding correct?
Sure, thank you. For further updates and specific queries, please visit www.sunpharma.com or feel free to contact Abhishek Sharma, +91 22 43242929, abhi.sharma@sunpharma.com, Gaurav Chugh, +91 22 43245373, gaurav.chugh@sunpharma.com,